Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Chandler H Park"'
Autor:
Yan Leyfman, Nancy Emmanuel, Gayathri P. Menon, Muskan Joshi, William B. Wilkerson, Jared Cappelli, Timothy K. Erick, Chandler H. Park, Pushpa Sharma
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-15 (2023)
Abstract Cancer patients, due to their immunocompromised status, are at an increased risk for severe SARS-CoV-2 infection. Since severe SARS-CoV-2 infection causes multiple organ damage through IL-6-mediated inflammation while stimulating hypoxia, an
Externí odkaz:
https://doaj.org/article/0c84d6029e0c4dd0a05bf9775a8ba0fe
Autor:
Yan Leyfman, William B. Wilkerson, Shubhadarshini G. Pawar, Muskan Joshi, Gayathri Pramil Menon, Alexandra van de Kieft, Chandler H. Park
Publikováno v:
Leading Edge of Cancer Research Symposium: Poster Session.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29007cb7993bc441aaca82973132885d
https://doi.org/10.52519/00064
https://doi.org/10.52519/00064
Publikováno v:
Leading Edge of Cancer Research Symposium: Poster Session.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2e7b7b110419a8fef01103bc828fc1a
https://doi.org/10.52519/00063
https://doi.org/10.52519/00063
Autor:
Daniel P. Petrylak, Scott T. Tagawa, Rohit K. Jain, Manojkumar Bupathi, Arjun V. Balar, Arash Rezazadeh, Saby George, Phillip Lee Palmbos, Luke T. Nordquist, Nancy B. Davis, Chethan Ramamurthy, Cora N. Sternberg, Yohann Loriot, Neeraj Agarwal, Chandler H. Park, Julia Tonelli, Morganna Vance, Huafeng Zhou, Petros Grivas
Publikováno v:
Journal of Clinical Oncology. 41:520-520
520 Background: Pts with PT-ineligible mUC have limited treatment options following CPI therapies; thus, new treatment options are needed. SG is an antibody-drug conjugate composed of an anti-Trop-2 antibody coupled to SN-38, a topoisomerase-I inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54ad590fd5d69c3a0e2135e7d97b5719
https://doi.org/10.1200/jco.2023.41.6_suppl.520
https://doi.org/10.1200/jco.2023.41.6_suppl.520
Autor:
Petros Grivas, Damien Pouessel, Chandler H. Park, Philippe Barthelemy, Manojkumar Bupathi, Daniel P. Petrylak, Neeraj Agarwal, Sumati Gupta, Aude Flechon, Chethan Ramamurthy, Nancy B. Davis, Alejandro Recio-Boiles, Cora N. Sternberg, Astha Bhatia, Cabilia Pichardo, Mitch Sierecki, Julia Tonelli, Huafeng Zhou, Scott T. Tagawa, Yohann Loriot
Publikováno v:
Journal of Clinical Oncology. 41:518-518
518 Background: Pembro is standard of care for pts with mUC who progress after 1L PT therapy but only ~21% of pts respond, highlighting an unmet need (Bellmunt, et al. NEJM. 2017). SG is an antibody-drug conjugate composed of an anti-Trop-2 antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07ca84153af76b7ef6bd5a3f64189872
https://doi.org/10.1200/jco.2023.41.6_suppl.518
https://doi.org/10.1200/jco.2023.41.6_suppl.518
Autor:
Scott T. Tagawa, Vision Investigators, Oliver Sartor, Bernd J. Krause, Alison Armour, Chandler H Park, Michael J. Morris, Euloge Kpamegan, Ken Herrmann, Luke T. Nordquist, Ghassan El-Haddad, Johann S. de Bono, Kambiz Rahbar, Richard A. Messmann, Nitin Vaishampayan, Michelle DeSilvio, Wendy J Pérez-Contreras, Tomasz M. Beer, Germo Gericke, Karim Fizazi, Kim N. Chi
Publikováno v:
N Engl J Med
BACKGROUND: Metastatic castration-resistant prostate cancer remains fatal despite recent advances. Prostate-specific membrane antigen (PSMA) is highly expressed in metastatic castration-resistant prostate cancer. Lutetium-177 ((177)Lu)–PSMA-617 is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d825e30bacceb4769fe507c6af4584b
https://doi.org/10.1016/j.eururo.2021.07.006
https://doi.org/10.1016/j.eururo.2021.07.006
Autor:
Euloge Kpamegan, Luke T. Nordquist, Ken Herrmann, Wendy J Pérez-Contreras, Michelle DeSilvio, Ghassan El-Haddad, Michael J. Morris, Johann S. de Bono, Nitin Vaishampayan, A. Oliver Sartor, Richard A. Messmann, Scott T. Tagawa, Bernd J. Krause, Chandler H. Park, Kambiz Rahbar, Kim N. Chi, Germo Gericke, Karim Fizazi, Tomasz M. Beer
LBA4 Background: Despite recent therapeutic advances, metastatic castration-resistant prostate cancer (mCRPC) remains invariably fatal. Prostate-specific membrane antigen (PSMA) is highly expressed in mCRPC lesions. 177Lu-PSMA-617 is a targeted radio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6268434c6bd7ec2f1a900d449909240d
Publikováno v:
Journal of Clinical Oncology. 40:e18560-e18560
e18560 Background: COVID-19 has contributed to healthcare inequity amongst minorities and lower socioeconomic populations, while complicating present anti-cancer treatment regimens. Due to their immunocompromised status, cancer patients are at an inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4364a322e0ee0e1fa5d083dbcab13c83
https://doi.org/10.1200/jco.2022.40.16_suppl.e18560
https://doi.org/10.1200/jco.2022.40.16_suppl.e18560
Autor:
Matthew Raymond Smith, Maha H. A. Hussain, Fred Saad, Karim Fizazi, Cora N. Sternberg, E. David Crawford, Evgeny Kopyltsov, Chandler H. Park, Boris Alexeev, Alvaro Montesa, Dingwei Ye, Francis Parnis, Felipe Melo Cruz, Teuvo Tammela, Hiroyoshi Suzuki, Heikki Joensuu, Silke Thiele, Rui Li, Iris Kuss, Bertrand F. Tombal
Publikováno v:
Journal of Clinical Oncology. 40:13-13
13 Background: Darolutamide (DARO) is a structurally distinct and highly potent androgen receptor inhibitor that demonstrated improved overall survival (OS) and metastasis-free survival vs placebo (PBO) and a low incidence of treatment-emergent adver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24442284215d0257506e61668157a92c
https://doi.org/10.1200/jco.2022.40.6_suppl.013
https://doi.org/10.1200/jco.2022.40.6_suppl.013
Publikováno v:
Blood. 138:4936-4936
With the rise of social media use during the COVID-19 pandemic, impressions from online content can affect behavioral changes resulting in exacerbating disparities in care. Thus, there exists a need to utilize social media platforms, like Twitter, to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b65af561ebd6e53282db4203ab1141e3
https://doi.org/10.1182/blood-2021-151709
https://doi.org/10.1182/blood-2021-151709